# Sutro Biopharma, Inc.: Form 8-K, filed Apr 14, 2023

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2023-04-14
- Accepted by EDGAR: Apr 14, 2023, 16:06 ET
- Period: 2023-04-10
- Accession: 0000950170-23-012879
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017023012879/stro-20230410.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017023012879/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017023012879/stro-20230410.htm

Filed Apr 14, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-012879. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.